Immunomodulatory agents as potential therapeutic or preventive strategies for COVID-19

R Gaziano, ES Pistoia, E Campione… - European Review for …, 2021 - art.torvergata.it
Abstract Currently, the COVID-19 pandemic, caused by the novel SARS-CoV-2 coronavirus,
represents the greatest global health threat. Most people infected by the virus present mild to …

Immunomodulatory drugs in the management of SARS-CoV-2

DR Burrage, S Koushesh, N Sofat - Frontiers in immunology, 2020 - frontiersin.org
With the onset of the global pandemic in 2020 of Severe Acute Respiratory Syndrome
Coronavirus-2 (SARS-CoV-2), there has been increasing research activity around certain …

Current and emerging immunomodulators for treatment of SARS-CoV2 infection (COVID-19)

MW McCarthy - Expert Opinion on Pharmacotherapy, 2022 - Taylor & Francis
ABSTRACT Introduction SARS-CoV-2, the virus that causes COVID-19, elicits a variety of
host responses ranging from asymptomatic or mild illness in most people, to severe disease …

[HTML][HTML] COVID-19 therapeutics: an update on effective treatments against infection with SARS-CoV-2 variants

BT Padasas, E Españo, SH Kim, Y Song, CK Lee… - Immune …, 2023 - ncbi.nlm.nih.gov
Abstract The coronavirus disease 2019 (COVID-19) pandemic is one of the most
consequential global health crises in over a century. Since its discovery in 2019, severe …

Plausibility of natural immunomodulators in the treatment of COVID-19–A comprehensive analysis and future recommendations

R Akter, MR Rahman, ZS Ahmed, A Afrose - Heliyon, 2023 - cell.com
The COVID-19 pandemic has inflicted millions of deaths worldwide. Despite the availability
of several vaccines and some special drugs approved for emergency use to prevent or treat …

Immunomodulatory agents for COVID-19 treatment: possible mechanism of action and immunopathology features

F Rommasi, MJ Nasiri, M Mirsaeidi - Molecular and cellular biochemistry, 2022 - Springer
The novel coronavirus pandemic has emerged as one of the significant medical-health
challenges of the current century. The World Health Organization has named this new virus …

[HTML][HTML] COVID-19: Considerations about immune suppression and biologicals at the time of SARS-CoV-2 pandemic

G Costanzo, W Cordeddu, L Chessa… - World Journal of …, 2021 - ncbi.nlm.nih.gov
The extent of the profound immunological and nonimmunological responses linked to
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is currently being …

Immunomodulatory-based therapy as a potential promising treatment strategy against severe COVID-19 patients: A systematic review

M Razmi, F Hashemi, E Gheytanchi… - International …, 2020 - Elsevier
The global panic of the novel coronavirus disease 2019 (COVID-19) triggered by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to an urgent requirement …

Immunomodulators acting on covid-19: Actual knowledge and perspectives

N Durán, WJ Fávaro - 2020 - preprints.org
Since the outbreak of SARS CoV-2 infection (Covid-19), healthcare professionals worldwide
have been trying to find disease management and control alternatives to encourage …

Pharmaco-immunomodulatory therapy in COVID-19

JG Rizk, K Kalantar-Zadeh, MR Mehra, CJ Lavie… - Drugs, 2020 - Springer
The severe acute respiratory syndrome coronavirus 2 associated coronavirus disease 2019
(COVID-19) illness is a syndrome of viral replication in concert with a host inflammatory …